Treatment of Symptomatic Lumbar Internal Disc Disruption (IDD) With the Biostat® System
Status:
Terminated
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this investigation is to establish the safety and efficacy of the Biostat
System when used for treatment of chronic low back (lumbar) pain due to symptomatic internal
disc disruptions (IDD) by comparing safety and efficacy outcome measures between one group
receiving BIOSTAT BIOLOGX® Fibrin Sealant through the Biostat® Delivery Device and another
group receiving a preservative-free normal saline control delivered with the Biostat Delivery
Device.